Berlin – A YPOG-Team led by Jens Kretzschmann and Julian Albrecht advised transatlantic Venture Capital Apollo Health Ventures on structuring its "Health Ventures Fund II". With capital commitments of $180 million (€157.5 million), the new fund reached its final closing while being oversubscribed. The new money was raised by Apollo's existing international investor base as well as experienced and well-known new investors. According to Apollo Health, the company will support the founding of new startups and finance existing businesses in the data-based biotechnology and healthcare technology sector. Based on groundbreaking scientific insights, Apollo focuses especially on investments that have the potential to treat, prevent or even completely cure age-related diseases to extend the human lifespan. For structuring the new fund, Apollo Health Ventures trusted in the expertise of a YPOG team led by Jens Kretzschmann and Julian Albrecht, who already supported the VC in structuring the first-generation fund in the past.
"The digital transformation has significantly changed the way we live and work. In conjunction with the latest groundbreaking discoveries from science and research, innovative solutions based on data-driven technologies are taking an important function in the healthcare sector. Considering the demographic developments worldwide, with a rising number of older people, the outstanding potential of Apollo Health Ventures' investments in companies for the detection, prevention, treatment and cure of age-related diseases becomes impressively obvious. We are pleased to support Apollo Health Ventures in structuring its second-generation fund," said partner Jens Kretzschmann.
Download PDF
Advisors Apollo Health Ventures:
Jens Kretzschmann (Co-Lead/Structuring, Tax), Partner
Dr. Julian Albrecht (Co-Lead/Structuring, Tax), Associated Partner
Dr. Niklas Ulrich (Regulatory), Associate
About Apollo Health Ventures
Apollo Health Ventures is a transatlantic Venture Capital specializing in the development and financing of data-driven biotechnology and healthcare technology companies. Apollo Health Ventures invests while Seed or Early-Stage financing rounds and develops companies in the Aging Health sector. Apollo's team includes entrepreneurs, experienced biotech investors, and scientists with significant expertise in life science investing and company formation.
About us
YPOG stands for You + Partners of Gamechangers – forward-thinking legal and tax advice. Supporting companies that are focused on emerging technologies, YPOG embraces change as an opportunity to develop cutting-edge solutions. The YPOG team offers comprehensive expertise in the areas of Funds, Tax, Transactions, Corporate, Banking, Regulatory + Finance, IP/IT/Data Protection, Litigation, and Corporate Crime + Compliance + Investigations. YPOG is one of the leading law firms in Germany for venture capital, private equity, fund structuring, and the implementation of distributed ledger technology (DLT) in financial services. Both the firm and its partners are regularly recognized by renowned national and international publications such as JUVE, Best Lawyers, Chambers and Partners, Leaders League, and Legal 500. YPOG is home to more than 150 experienced attorneys, tax advisors and tax specialists as well as a notary, working across offices in Berlin, Hamburg, Cologne, and Munich.
Further information: www.ypog.law/en/ and www.linkedin.com/company/ypog
